Clinical Trials Browser

Terminated × Oxaliplatin × Other solid neoplasm × Clear all

NCT02648711 2020-05-28

Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumors

NCT00066625 2013-02-01

Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00086983 2013-01-10

Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific